| Literature DB >> 26643292 |
D Kratzsch1, J-C Simon2, R Treudler2.
Abstract
Pharmacotherapy in the elderly represents a challenge for dermatologists in regard to comorbidities, drug interactions, and compliance. Age-associated multimorbidity often results in polypharmacy and elevates the risk of adverse drug reactions. Crucial age-related alterations in pharmacokinetics must be considered when selecting drugs, particularly decreased total body water, altered proportion between muscle mass and adipose tissue, as well as decreased renal function. The purpose of this review is to help the reader identify relevant adverse drug reactions of often prescribed systemic dermatological pharmacons in geriatric patients and makes recommendations for their adequate application.Entities:
Keywords: Drug interactions; Geriatric dermatology; Pharmacokinetics; Pharmacotherapy; Polypharmacy
Mesh:
Year: 2016 PMID: 26643292 DOI: 10.1007/s00105-015-3731-9
Source DB: PubMed Journal: Hautarzt ISSN: 0017-8470 Impact factor: 0.751